Supernus Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Rockville, MD
SUPN chart
What traders are saying about $SUPN
Latest postsSupernus Pharmaceuticals, Inc. news
- Supernus Pharmaceuticals (SUPN) Is Back In The Spotlight, But Why?
Simply Wall Street ·
- Supernus Pharmaceuticals ends UBS credit line ahead of Indivior merger By Investing.com
Investing.com Australia ·
- Supernus Pharmaceuticals - Terminates UBS Credit Line Agreement On October 20, 2026 - SEC Filing
TradingView ·
- Form 8K Supernus Pharmaceuticals Inc For: 26 October By Investing.com
Investing.com Canada ·
- Supernus Pharmaceuticals Ends UBS Credit Line Ahead of Indivior Combination
TradingView ·
- Supernus Pharmaceuticals, Inc. Announces Termination of Credit Line Agreement with UBS Bank USA
www.marketscreener.com ·
- Biogen Q3 Preview: Will Growth Products Drive an Earnings Beat?
Yahoo Finance ·
- Arrowhead Pharmaceuticals And 2 Biotech Stocks To Own
Yahoo Finance ·
- Is Supernus Pharmaceuticals Inc (SUPN) a Bargain After 3.3% Drop? GF Value Says Undervalued
GuruFocus ·
- Supernus Pharmaceuticals, Inc. Estimates – NASDAQ:SUPN
TradingView ·
- Huron Consulting stock rises on S&P SmallCap 600 addition
Yahoo Finance ·
- MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600
Yahoo Finance ·
Supernus Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $719.0M | $661.8M | $607.5M | $667.2M |
| Net income | -$38.6M | $73.9M | $1.3M | $60.7M |
| Diluted EPS | $-0.68 | $1.32 | $0.02 | $1.04 |
| Total assets (year end) | $1.45B | $1.37B | $1.28B | $1.70B |
| Cash and equivalents (year end) | $128.4M | $69.3M | $75.1M | $93.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Supernus Pharmaceuticals, Inc.
- Ticker
- SUPN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Rockville, MD
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1356576
- Former names
- SUPERNUS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Supernus Pharmaceuticals, Inc. listed on?
Supernus Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol SUPN.
What industry is Supernus Pharmaceuticals, Inc. in?
Supernus Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Supernus Pharmaceuticals, Inc. headquartered?
Supernus Pharmaceuticals, Inc.'s business address on file with the SEC is in Rockville, MD.
When does Supernus Pharmaceuticals, Inc.'s fiscal year end?
Supernus Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Supernus Pharmaceuticals, Inc. report?
Supernus Pharmaceuticals, Inc. reported $719.0M in revenue for calendar year 2025, according to its SEC filings.